Bill Ackman - Pershing Square Capital Management
As of Q2 2026, Bill Ackman reported 14 long-equity positions worth $19.47B in aggregate.
Copy-investor backtest
- Latest quarter
- +1.96%
- 1-year
- +15.11%
- 3-year
- +41.35%
- 5-year
- +50.23%
- 3-year vs S&P 500
- -31.89%
- 5-year vs S&P 500
- -23.45%
- 5-year top 5
- +52.69%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when Bill Ackman files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 6 of 9 rows. Rows without a quote are marked unavailable.
| 1 | ZTS | ZOETIS INC | 20.94% | - | 41,823,145 | $1.85B | $44.33 | No quote |
| 2 | CP | CANADIAN PAC RY LTD | 20.89% | - | 13,940,890 | $1.85B | $132.69 | No quote |
| 3 | QSR | RESTAURANT BRANDS INTL INC | 17.17% | Add +3.0% | 39,150,551 | $1.52B | $38.83 | No quote |
| 4 | APD | AIR PRODS & CHEMS INC | 12.37% | Reduce -63.0% | 7,601,140 | $1.09B | $144.05 | No quote |
| 5 | MDLZ | MONDELEZ INTL INC | 10.40% | Reduce -47.1% | 22,942,225 | $920.44M | $40.12 | No quote |
| 6 | VRX | VALEANT PHARMACEUTICALS INTL | 6.41% | Add +30.1% | 21,591,122 | $567.85M | No quote | No quote |
| 7 | HHC | HOWARD HUGHES CORP | 4.27% | - | 3,568,017 | $377.82M | No quote | No quote |
| 8 | PAH | PLATFORM SPECIALTY PRODS COR | 4.15% | - | 42,737,394 | $367.54M | No quote | No quote |
| 9 | NOMD | NOMAD HLDGS LTD | 3.39% | New | 33,333,334 | $300.33M | $9.01 | No quote |